These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23505793)

  • 1. Ocular graft vs. host disease after hematopoietic stem cell transplantation.
    Rumery TC; Mian SI
    Insight; 2013; 38(1):11-8. PubMed ID: 23505793
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular graft-versus-host disease after allogeneic stem cell transplantation.
    Westeneng AC; Hettinga Y; Lokhorst H; Verdonck L; van Dorp S; Rothova A
    Cornea; 2010 Jul; 29(7):758-63. PubMed ID: 20489577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jaundice after allogeneic hematopoietic stem cell transplantation.
    Mendizabal M; Chen T; Reddy KR
    Hepatology; 2009 Dec; 50(6):2044-5. PubMed ID: 19937681
    [No Abstract]   [Full Text] [Related]  

  • 4. Current insights into ocular graft-versus-host disease.
    Riemens A; te Boome L; Imhof S; Kuball J; Rothova A
    Curr Opin Ophthalmol; 2010 Nov; 21(6):485-94. PubMed ID: 20729735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation with peripheral blood stem cells from unrelated donors without serious graft-versus-host disease.
    Ringdén O; Lönnqvist B; Hägglund H; Ljungman P; Shanwell A; Lawlor E; Schmitz N
    Bone Marrow Transplant; 1995 Dec; 16(6):856-7. PubMed ID: 8750284
    [No Abstract]   [Full Text] [Related]  

  • 7. [Management of late complications after allogeneic hematopoietic stem cell transplantation].
    Kurosawa S; Fukuda T
    Rinsho Ketsueki; 2013 Feb; 54(2):167-76. PubMed ID: 23470823
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hematopoietic stem cell transplantation].
    Sato N
    Rinsho Byori; 2001 Mar; Suppl 115():103-10. PubMed ID: 11391926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status and issues in hematopoietic stem cell transplantation].
    Harada M
    Fukuoka Igaku Zasshi; 2007 Feb; 98(2):35-47. PubMed ID: 17396570
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute graft-versus-host disease following hematopoietic stem-cell transplantation.
    Hu SW; Cotliar J
    Dermatol Ther; 2011; 24(4):411-23. PubMed ID: 21910799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complications of hematopoietic stem cell transplantation: physiopathology and management. 2. Graft-versus-host disease (GVHD)].
    Morishita Y
    Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1502-9. PubMed ID: 9780678
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation.
    Bieri S; Roosnek E; Ozsahin H; Huguet S; Ansari M; Trombetti A; Helg C; Chapuis B; Miralbell R; Passweg J; Chalandon Y
    Eur J Haematol; 2011 Aug; 87(2):138-47. PubMed ID: 21535161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anesthesia and graft-vs-host disease after hematopoietic stem cell transplantation.
    Thiruvenkatarajan V; Rebecca J
    Paediatr Anaesth; 2007 Jan; 17(1):7-15. PubMed ID: 17184425
    [No Abstract]   [Full Text] [Related]  

  • 14. MPO is a potential biomarker of acute graft-versus-host disease.
    Ge B; Ye H
    Biomark Med; 2013 Jun; 7(3):391-3. PubMed ID: 23734800
    [No Abstract]   [Full Text] [Related]  

  • 15. Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease.
    Bastos Oreiro M; Castilla-Llorente C; de la Guía AL; de Paz R; Van Domselaar M; Nieto J; Rodriguez A; Gallardo D; Canales M;
    Bone Marrow Transplant; 2012 Sep; 47(9):1241-2. PubMed ID: 22307017
    [No Abstract]   [Full Text] [Related]  

  • 16. Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia.
    Lee JH; Lee JH; Kim DY; Yun SC; Kim SD; Choi Y; Lee YS; Kang YA; Jeon MJ; Seol M; Lee KH
    Eur J Haematol; 2011 Aug; 87(2):172-81. PubMed ID: 21599753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular graft-versus-host disease.
    Hessen M; Akpek EK
    Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):540-7. PubMed ID: 22892710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy for Ocular Graft-vs-Host Disease].
    Steven P; Sauerbier L; Siebelmann S; Gehlsen U; Tahmaz V; Wittig S; Scheid C; Cursiefen C
    Klin Monbl Augenheilkd; 2015 May; 232(5):658-63. PubMed ID: 25989035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic PBPC transplantation: an effect on incidence and distribution of chronic graft-versus-host disease without long-term survival benefit?
    Snowden JA; Nivison-Smith I; Atkinson K; Fay K; Concannon A; Dodds A; Milliken S; Biggs J
    Bone Marrow Transplant; 2000 Jan; 25(1):119-20. PubMed ID: 10654027
    [No Abstract]   [Full Text] [Related]  

  • 20. Bandage and scleral contact lenses for ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Stoyanova EI; Otten HM; Wisse R; Rothova A; Riemens A
    Acta Ophthalmol; 2015 Nov; 93(7):e604. PubMed ID: 25923173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.